Arca
Skip to content
Tools
Tools

Max-Face Maxillofacial Osteosynthesis System

Plate, Bone. 510(k) K073307, from Bio-Technology USA, Inc. (Austin, TX). Product code JEY, class 2.

As of Nov 18, 2026, K073307 is an FDA 510(k) held by Bio-Technology USA, Inc., substantially equivalent on Oct 29, 2008 after 341 days, with no recalls tied to it in FDA's recall database.

  • Review time: 341 days
  • Recalls: 0

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

The MaxFace Maxillofacial Ostheosynthesis System is indicated for trauma fixation of the superior, middle and inferior segments of the facial skeleton, for osteosynthesis of corrective osteotomies in congenital deformities treatment (acquired or in development) and for the fixation of grafts in reconstructive surgeries.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other JEY clearances

The newest 510(k)s for the same product code; their median review was 213 days; see every JEY device

Record

Type
Traditional
Received
Nov 23, 2007
Review panel
Dental
Regulation
21 CFR 872.4760

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.